ClinicalTrials.Veeva

Menu

Skeletal Muscle Mass Used to Assess Frailty in Older Gastric Cancer Patients

N

Nanjing Medical University

Status

Completed

Conditions

Malnutrition Elderly
Frailty
Sarcopenia
Gastric (Stomach) Cancer

Treatments

Other: Skeletal muscle mass and frailty

Study type

Observational

Funder types

Other

Identifiers

NCT06763068
2020-273-2

Details and patient eligibility

About

The primary aim of this study was to quantify the diagnosis of pre-surgical skeletal muscle mass in elderly gastric cancer patients and to analyse its correlation with frailty. The second aim was to investigate whether skeletal muscle mass, or sarcopenia, is associated with mobility and nutritional status, and anxiety and depression. The main questions it aims to answer are whether skeletal muscle mass is significantly associated with frailty and whether it can be used as a brief screening tool for preoperative frailty.

Enrollment

575 patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosed with gastric cancer by endoscopy or pathology; age >60 years old; radical gastrectomy was proposed; be able to communicate simply in writing and verbal.

Exclusion criteria

  • received preoperative radiotherapy or chemotherapy; combined with other sites of malignant tumors; combined with severe heart, liver, lung and renal insufficiency; recent using hormones, immunosuppressants; with physical disabilities.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems